Erratum to: PI3K/mTOR inhibition can impair tumor invasion and metastasis in vivo despite a lack of antiproliferative action in vitro: implications for targeted therapy

Ítems similars

• PI3K/mTOR inhibition can impair tumor invasion and metastasis in vivo despite a lack of antiproliferative action in vitro: implications for targeted therapy
  per: Wander, Seth A., et al.
  Publicat: (2013)
• Next-generation mTOR inhibitors in clinical oncology: how pathway complexity informs therapeutic strategy
  per: Wander, Seth A., et al.
  Publicat: (2011)
• p27: A Barometer of Signaling Deregulation and Potential Predictor of Response to Targeted Therapies
  per: Wander, Seth A., et al.
  Publicat: (2010)
• p27 transcriptionally coregulates cJun to drive programs of tumor progression
  per: Yoon, Hyunho, et al.
  Publicat: (2019)
• Pyrazolopyrimide library screening in glioma cells discovers highly potent antiproliferative leads that target the PI3K/mTOR pathway
  per: Valero, Teresa, et al.
  Publicat: (2020)